Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Rhinitis, Allergic

• Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray
• Azelastine Allergen Chamber - Onset of Action Study
• Nasal Allergen Challenge Test as a Method to Detect Clinical Reactivity Against Birch Pollen
• Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT
• Nasal Irrigation With Chinese Herbal Medicine as an Adjunctive Treatment in Allergic Rhinitis
• Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis
• Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above
• Acupuncture for Nasal Congestion in Allergic Rhinitis (ANCAR)
• A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis
• Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER)
• Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil
• To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic Rhinitis
• Diphenhydramine and Sweating
• Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR
• Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients
• Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult Participants
• Impact Of Montelukast On Allergic Rhinitis And Its Inflammatory Makers
• Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis
• Application of Artemisia Pollen Specific Allergen Immunotherapy in Patients With Allergic Rhinitis in Autumn
• Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis
• As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis
• Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract
• The Effect of Early Radiofrequency Turbinate Reduction on Persistent Allergic Rhinitis
• Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis
• Fixed Dose Combination of DESloratadine / PREDnisolone in the Treat. of Moderate - Severe Allergic Rhinitis in Children
• Documentation of Efficacy of Intralymphatic Allergen Immunotherapy
• Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects
• A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass Pollen
• Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis
• Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis
• Early Intervention in Allergic Patients
• Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis
• A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat
• The Effects of Using Yupingfeng Powder With Variation for the Treatment of Allergic Rhinitis
• Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age
• Study on the Correlation Between Intestinal Microecology and Allergic Diseases in Children
• Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis
• Effects of Second-generation Antihistamine Bepotastine on Cough Outcomes in Cough Patients With Allergic Rhinitis
• Effect of Sublingual Immunotherapy on Platlet factor4 Level in Children
• To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray
• Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
• The Influence of Nonspecific Immunostimulation on Changes in the Concentration of iNKT Cells
• Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis
• Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients
• Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis
• An Exploratory Study of PQ Grass 27600 SU
• Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis
• Dymista Allergen Chamber - Onset of Action Study
• Effect of Bacterial Lysate on Nasal Carriage of Staphylococcus Aureus
• Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.
• Collaborative Care Model for Allergic Rhinitis With Obstructive Sleep Apnea From Prevention to Treatment.
• miRNA-155 Assay Before and After Immunotherapy and Probiotics
• Allergic Rhinitis Combination Pharmacotherapy Efficacy Study
• Comparison of Montelukast and Azelastine in Treatment of Moderate to Severe Allergic Rhinitis
• Study to Find Out Whether Participants With a History of Stuffy Nose Due to Allergic Reactions in the Nose Would Intend to Buy Drug Phenylephrine Hydrochloride Extended Release Tablets After Receiving it Once in This Study
• Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis
• The Efficacy of Preseasonal Omalizumab Treatment
• Traditional Chinese Medicine for the Treatment of Perennial Allergic Rhinitis on Gut Microbiota and Immune-modulation
• Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene
• Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis
• Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass
• Efficacy Of Bacterial Lysate In Children With Allergic Rhinitis
• Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis
• Is Intralymphatic Allergen Immunotherapy Effective and Safe?
• Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline
• "Efficacy and Safety of Phlai Capsule Compared to Placebo as the Treatment in Allergic Rhinitis Patients"
• A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of Allergies
• Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy Volunteers
• The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients With Allergic Asthma
• Compare the Effect of INS Alone and Added LTRA in Treatment of SAR
• Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua
• Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis
• Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)
• Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)
• Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184)
• Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
• Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
• Effect of the Nasal Gel "Nascum®-Plus" on Allergic Symptoms
• Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray
• Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis
• Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of Pollutants
• Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis
• DYmista NAsal Spray in CHInese Patients
• A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients
• Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy
• Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)
• Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)
• A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure
• Role of Montelukast in Asthma and Allergic Rhinitis Patients
• Benjakul Extract and Loratadine for Treatment Allergic Rhinitis Patients
• Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children
• Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients
• A Novel Biologic Therapy for Perennial Allergic Rhinitis
• Nebulized Resveratrol Plus Carboxymethyl-β-Glucan for Reducing IL-5 in Children With Allergic Rhinitis
• The Effect of Cetirizine on Bronchoconstriction
• A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)
• Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis
• A Dose-finding Study of ASP4070
• Traditional Chinese Medicine on Gut Microbiota and Allergic Diseases
• Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis
• MP-AzeFlu Allergen Chamber - Onset of Action Study
• Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis
• Intralymphatic Immunotherapy in Increasing Doses, Substudy
• Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis
• Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis
• Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis
• Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis
• ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen
• Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)
• Effects of Broccoli Sprout Extract on Allergy Rhinitis
• Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)
• Drug Utilization Study for Pirinase Hayfever Relief
• Effectiveness of Bifidobacteria in Children Affected by Seasonal Allergic Rhinitis
• Allergic Rhinitis, Immunotherapy and Vitamin d
• Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study
• Exploratory Study for Allergy Relief Onset
• Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)
• The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis
• Efficacy of 2LALERG (Homeopathic Drug) in Allergic Rhinitis Related to Grass Pollen
• Repeated Dosing Clinical Trial of HL151
• Single Dosing Clinical Trial of HL151
• Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy
• Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis
• Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis.
• Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis
• Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)
• Tolerability of SLIT With LAIS® Mites Allergoid Tablets
• A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma
• Sanfu Herbal Patch and Sanfu Moxibustion for Persistent Allergic Rhinitis: a Controlled Clinical Trial
• Study of Efficacy and Safety of Ginger Extract Compared With Loratadine for Treatment of Allergic Rhinitis
• Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria
• Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis
• 4"S" - Seasonal Symptoms Suppression Study
• Efficacy and Safety of HCP1102 Capsule
• Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis
• Comparability and Standardization of Controlled Allergen Challenge Facilities
• Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine
• Anti-inflammatory H1 Antihistamines Allergic Rhinitis
• Clinical Trial to Evaluate the Efficacy and Safety of CKD-342
• The Oligonucleotide Chip Analysis for Allergic Rhinitis Treatment in Herbal Plaster and Acupuncture
• Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)
• Trial of Tian Jiu Therapy for Allergic Rhinitis
• Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX®
• A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)
• Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy
• Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis
• Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis
• A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic Rhinitis
• Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays
• The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation
• Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis
• Airway Inflammation in Children With Allergic Rhinitis and Intervention
• Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis
• Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
• To Study GSP 301 in Patients With Seasonal Allergic Rhinitis
• Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis
• A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis
• A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis
• Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients
• Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)
• Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™
• Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients
• Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis
• AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)
• Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus
• Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet
• Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis
• The Efficacy and Safety of Sanfujiu on Patients With Persistent Allergic Rhinitis: Randomized Controlled Study
• WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis
• Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis
• Evaluation of Efficacy of Dellegra in Exposure Unit
• Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber
• Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia
• Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal Esketamine
• Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray
• Evaluation of the Beneficial Effects of a Nasal Spray of Resveratrol in Children With Seasonal Allergic Rhinitis
• Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
• A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers
• Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium)to Treat Asthma
• Controlled Trial of Chinese Herbal Medicine to Treat Allergic Rhinitis
• Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
• Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study
• Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests
• NoAL (HPMC) in Combination With Oxymetazoline in Patients With Allergic Rhinitis
• The Effects of Immunotherapy in the Nose
• Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean
• Leukotriene D4 Nasal Provocation Test in Allergic Rhinitis
• A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine
• A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)
• A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis
• Alpha-Blockers in Allergic Rhinitis (MAN 01)
• Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis
• A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)
• A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
• Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
• A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
• PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg
• Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen
• Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR
• The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions
• The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
• Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519)
• Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate
• Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520)
• Allergic Rhinitis Changes the Sinus Microbiome
• Clinical Equivalence Study of Mometasone Nasal Spray
• Hair Cortisol in Asthma or Allergic Rhinitis Treated With Topical Corticosteroids
• Assessment of Fluticasone Propionate on Ocular Allergy Symptoms
• A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber
• 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
• To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies
• Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
• Study of Bronchodilation Effects of Cetirizine
• Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR)
• Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis
• Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen
• Effect of Nasaleze on Nasal Challenge With Allergen
• Comparison of Desloratadine Associated With Prednisolone (Tablet)Versus Dexchlorpheniramine Associated With Betamethasone (Tablet) for Adult Persistent Allergic Rhinitis Treatment
• Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy
• Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen
• Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
• Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)
• A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)
• A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)
• Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge
• A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)
• Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis
• A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627)
• Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients
• SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding
• Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis
• Effect of Qi-tonifying Chinese Herbal Products for Treatment of Allergic Rhinitis
• Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis
• Pharmacokinetic Study of Levocetirizine Oral Solution
• Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis
• Safety and Efficacy of SPARC1203 in Allergic Rhinitis
• House Dust Mite SLIT in Elderly Patients
• PILOT STUDY OF THE EFFICACY AND SAFETY OF WF10 IN SUBJECTS SUFFERING FROM PERSISTENT ALLERGIC RHINITIS
• Safety Study of Levocetirizine and Fexofenadine
• Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.
• Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis
• Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
• Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy
• Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis
• Clinical Trial to Evaluate the Safety and Efficacy of "CITUS Dry Syrup" in Children With Perennial Allergic Rhinitis
• Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol
• Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies
• Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Persistent Allergic Rhinitis Treatment
• Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation
• Effects of Whole Sprouts on Airway Allergic Inflammation
• Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
• An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics.
• Regulatory Lymphocytes in Patients Treated With Specific Immunotherapy
• Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis
• A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712)
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
• A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis
• Drug Use Investigation for XYZAL®
• Efficacy of Buffered Hypertonic Saline(BHS)Nasal Irrigation in Allergic Rhinitis (AR) Children
• An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo
• Omnaris Versus Levocetirizine Phase 4 Study
• A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
• Intranasal SB-705498 in Allergic Rhinitis (AR) Patients
• Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1)
• Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray
• Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis
• Fluticasone and Salmeterol in Allergic Rhinitis
• Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis
• Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis
• A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)
• A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhaler
• A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies
• Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Parti
• Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting
• Effects of Phenylephrine on Nasal Congestion in Participants With Seasonal Allergic Rhinitis (P08156 AM2)(Completed)
• Rhinitis, Cognition and Driving Performance
• Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies
• Fexofenadine HCL - Pseudoephedrine HCL Combination Versus Allegra in Patients With Seasonal Allergic Rhinitis
• Trial of STAHIST in Seasonal Allergic Rhinitis
• Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children
• Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis
• A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
• Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis
• A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis
• NasoNeb Delivery of an Intranasal Steroid
• Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge
• Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis
• Efficacy of Sublingual Immunotherapy in Polysensitized Allergic Rhinitis Patients
• Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR)
• Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis
• Comparison of Different Up-dosing Schedules With Osiris
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis
• Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic Rhinitis
• Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.
• Safety and Tolerability Study of Ragweed SLIT Tablets
• Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber
• Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers
• A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures
• Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children
• Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays
• Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal Sprays
• Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848
• Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects
• A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1)
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis
• Nasacort AQ Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Children With Allergic Rhinitis
• A Study of RO4989991 in Patients With Allergic Rhinitis
• Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)
• Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)
• Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)
• Theophylline in Rhinitis
• Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension
• Assessment of Oxidative Stress Markers in the Upper and Lower Airways of Atopic Children Treated With Nebulized Beclomethasone
• A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine
• Vitamin D Plus Fluticasone Propionate
• A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine
• Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis
• Flixonase Safety in Patients With Allergic Rhinitis (AR)
• An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to Placebo
• A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
• Study to Investigate Effects of CAL-263 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber
• A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response.
• Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy
• Grazax Asthma Prevention
• PURETHAL Grasses Rush Study
• Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis
• A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies
• Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites
• A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
• Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis
• The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis
• Management of Allergic Rhinitis Patients With Nasal Steroids and NeilMed® Sinus Rinse™ System With Isotonic Saline
• Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)
• Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic Rhinitis
• A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
• A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance
• Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older
• Study of AHIST in Seasonal Allergic Rhinitis Patients
• Randomized, Placebo Controlled, Crossover Study in an Environmental Challenge Chamber to Assess Safety & Efficacy of Three Oral Doses of BI 671800 Versus Fluticasone Propionate and Montelukast in Sensitive Seasonal Allergic Rhinitis Patients Out of
• Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms
• Regulatory AVAMYS Nasal Spray PMS
• 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine
• Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis
• Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 Mcg in Allergic Rhinitis
• A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis
• Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)
• Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)
• Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)
• Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients
• Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)
• 723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover
• A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED)
• Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)
• Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428)
• Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)
• A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)
• Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis
• A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
• Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis
• Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR
• Clinical Trial of STAHIST in Seasonal Allergic Rhinitis Patients
• Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal Rhinitis
• DSP-3025 Study of Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season
• The Effect of Nasal Carbon Dioxide (CO2) in the Symptomatic Treatment of Seasonal Allergic Rhinitis
• The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis
• Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876)
• Steroid Sparing Effect of Nasal Corticosteroid In Asthma And Rhinitis
• Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
• Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836)
• MOA Study of Ze 339 in Seasonal Allergic Rhinitis
• Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR
• Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo
• A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber
• Preventing Tolerance to Oxymetazoline in Allergic Rhinitis
• Azelastine Fluticasone Combination vs. Fluticasone
• Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid
• Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber
• Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270)
• A Study of the Effects of Single Dose Corticosteroids on Response to Allergens
• Is Levocetirizine Less Sedating Than Cetirizine?
• Comparative Study of Sinol and Sinol-M in Patients With Congestion Due to Allergic Rhinitis
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
• Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With Placebo
• Effectiveness of Individualized Homeopathic Treatment in Perennial Allergic Rhinitis
• Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)
• Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED)
• Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)
• Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticoste
• Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442)
• Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472)
• An Efficacy Study of JNJ-39220675 and Pseudoephedrine in Participants With Allergic Rhinitis
• Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children
• Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180)
• Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826)
• Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)
• Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)
• Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181)
• Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03829)(COMPLETED)
• Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179)
• Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age
• A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray
• Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen
• Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)
• Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
• Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis
• The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)
• A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber
• Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208)
• Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis
• Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)
• A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)
• Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED)
• Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)
• Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177)
• Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)
• A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)
• Olopatadine Eye Drops and Allergy Skin Testing
• Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
• MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED)
• Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848
• Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)
• Study to Evaluate Diphenhydramine in Children and Adolescents
• Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634)
• Efficacy and Safety Study of BLX-028914 in Subjects With Allergic Rhinitis
• Effect of Intranasal Corticosteroids on Systemic Allergen Specific IgE
• Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis
• A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
• Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)
• Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529)
• A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)
• Post Approval Pharmacokinetic Study of Loratadine in Japanese Pediatric and Adult Patients (Study P05539)
• A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis
• Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)
• A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis
• Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)
• A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis
• A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies
• A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies
• Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299)
• OC000459 Dose Finding Study in Hay Fever Sufferers.
• Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects
• Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial
• Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season
• The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Seasonal Allergic Rhinitis
• A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis
• To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis
• Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis
• Study of the Effect of SCH 900538 on Congestion in Subjects With Seasonal Allergic Rhinitis (Study P05031)(COMPLETED)
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
• To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)
• To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)
• Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)
• Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407)
• Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408
• To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)
• A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
• New Nasal Applicator / New Formulation - User Study
• Assess the Efficacy and Safety of Rhinocort Aqua
• Rhinocort Aqua Versus Placebo and Fluticasone Propionate
• Children, Perennial Allergic Rhinitis (PAR), l-t Growth
• Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic Rhinitis
• The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis
• Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen
• A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms
• Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposu
• Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine
• Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel
• Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine
• Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months
• A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis
• Safety and Tolerability of Single and Multiple Doses of VAK694 in Healthy and Atopic Subjects
• Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract
• Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin
• Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?
• A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)
• A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis
• Acupuncture for Seasonal Allergic Rhinitis
• A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis
• Investigation Of a New Oral Anti-Histamine in Healthy Male Subjects
• The Effect of Omalizumab on Responses to Cat Allergen Challenge
• A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adults
• An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma
• The Role of Montelukast in Rhinitis and Sleep
• Intranasal Steroids and Oxymetazoline in Allergic Rhinitis
• An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever
• Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
• Safety Study of Olopatadine Nasal Spray
• Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
• PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)
• Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.
• Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)
• A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge
• A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis
• Montelukast as a Controller of Atopic Syndrome
• Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)
• Singulair(R) In Asthma And Allergic Rhinitis (0476-383)
• Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects
• Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis
• Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS
• An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure Chamber
• Taste and Local Tolerance Study of NLA Nasal Spray in Patients With Allergic Rhinitis
• To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis
• Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis
• Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites
• Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR
• Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS
• A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.
• Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity
• Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis
• Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
• This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)
• Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED)
• Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis
• Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis
• Differential Adrenoreceptor Mediated Tachyphylaxis and Upregulation
• Study to Compare the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Placebo on Symptoms in Patients With Allergic Rhinitis Within/Out of Season
• Intranasal Steroids and the Nasal Ocular Response
• Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)
• Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol Supplements
• A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis
• Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)
• Herbal Treatment for Perennial Allergic Rhinitis
• Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)
• Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)
• MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)
• Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic Rhinitis
• Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)
• Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis
• Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
• Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma
• Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber
• Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen
• Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)
• Twin SUBLIVAC® Grasses Clinical Efficacy Study
• A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber
• A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
• Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)
• Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684)
• Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber
• Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis
• Fluticasone Nasal Spray Patient Preference Study
• To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)
• Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo
• A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)
• Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)
• Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber
• Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
• Study of GW685698X In Patients With Seasonal Allergic Rhinitis
• Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis
• The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726)
• Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)
• Study Of Perennial Allergic Rhinitis
• Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis
• Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)
• Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)
• DNA Vaccine for Ragweed Allergic Adults
• Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms in Patients With Allergic Rhinitis
• Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED)
• Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug
• Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen
• Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)
• Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008
• Study Of Patients With Allergic Rhinitis And Asthma
• Study Of Allergic Rhinitis In Patients Who Also Have Asthma
• Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects
• A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen
• The Effects of OC000459 on Nasal Mediators
• Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)
• Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma
• The Effects of Phenylephrine Compared With Those of Placebo and Pseudoephedrine on Nasal Congestion in Subjects With Seasonal Allergic Rhinitis (SAR)(P04579)
• Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)
• Perennial Allergic Rhinitis In Pediatric Subjects
• Study Of Perennial Allergic Rhinitis In Pediatrics
• A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy
• Safety and Efficacy Study of rEV131 in Allergic Rhinitis
• Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis
• Study In Adults And Adolescents With Seasonal Allergic Rhinitis.
• Long Term Safety Of GW685698X Via Nasal Biopsy
• A Study in Subjects With Perennial Allergic Rhinitis
• Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
• Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)
• Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)
• Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)
• ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)
• LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)
• POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)
• A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)
• EWO1 in Persistent Allergic Rhinitis Patients
• Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis
• An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis
• An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)
• The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis
• Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action
• Nasal Ocular Reflexes Contribute to Eye Symptoms
• A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics
• A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults
• Study In Adults And Adolescents With Seasonal Allergic Rhinitis
• 7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis
• Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray
• Perennial Allergic Rhinitis Study In Pediatric Subjects
• Seasonal Allergic Rhinitis In Pediatric Subjects
• A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).
• An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)
• The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)
• Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
• Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)